With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...

(Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more ... with Lilly's Zepbound or Novo's ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ...

By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

THIS VIDEO CONTAINS CONTENT SOME PEOPLE MAY FIND DISTRESSING“There is this one kid who called me pregnant because of my ...

Facing relentless bullying and health issues linked to obesity, some American teens are turning to Wegovy, a weight-loss drug ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Investing.com -- The American College of Cardiology released new recommendations on Friday stating that millions more ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Ozempic and Wegovy grabbed headlines after international celebrities ... say experts. Presently in India, Novo Nordisk is ...